EUVIMEDEUVIMED entdecken
Crossref

VENOM-DERIVED PEPTIDE E8 FROM LONOMIA OBLIQUA MODULATES NF-ΚB SIGNALING, EXTRACELLULAR MATRIX REMODELING AND CYTOPROTECTIVE RESPONSES IN IL-1Β–INFLAMED ARTICULAR CHONDROCYTES: A PROTEOMIC ANALYSIS

Amanda Teixeira de Melo, Hellen P. Valerio, MIRYAM PAOLA ALVAREZ-FLORES, Hugo Vigerelli, Giuseppe Palmisano, Ana M. Chudzinski-Tavassi

Osteoarthritis and Cartilage · 2026-04 · 34 · S83

DOI: 10.1016/j.joca.2026.01.089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026-04. Verfasst von Amanda Teixeira de Melo und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Melo, A. T. D., Valerio, H. P., ALVAREZ-FLORES, M. P., Vigerelli, H., Palmisano, G., & Chudzinski-Tavassi, A. M. (2026). VENOM-DERIVED PEPTIDE E8 FROM LONOMIA OBLIQUA MODULATES NF-ΚB SIGNALING, EXTRACELLULAR MATRIX REMODELING AND CYTOPROTECTIVE RESPONSES IN IL-1Β–INFLAMED ARTICULAR CHONDROCYTES: A PROTEOMIC ANALYSIS. Osteoarthritis and Cartilage, 34, S83. https://doi.org/10.1016/j.joca.2026.01.089

Vancouver

Melo ATD, Valerio HP, ALVAREZ-FLORES MP, Vigerelli H, Palmisano G, Chudzinski-Tavassi AM. VENOM-DERIVED PEPTIDE E8 FROM LONOMIA OBLIQUA MODULATES NF-ΚB SIGNALING, EXTRACELLULAR MATRIX REMODELING AND CYTOPROTECTIVE RESPONSES IN IL-1Β–INFLAMED ARTICULAR CHONDROCYTES: A PROTEOMIC ANALYSIS. Osteoarthritis and Cartilage. 2026;34:S83. doi:10.1016/j.joca.2026.01.089

BibTeX
@article{Melo2026,
  author = {Melo, Amanda Teixeira de and Valerio, Hellen P. and ALVAREZ-FLORES, MIRYAM PAOLA and Vigerelli, Hugo and Palmisano, Giuseppe and Chudzinski-Tavassi, Ana M.},
  title = {VENOM-DERIVED PEPTIDE E8 FROM LONOMIA OBLIQUA MODULATES NF-ΚB SIGNALING, EXTRACELLULAR MATRIX REMODELING AND CYTOPROTECTIVE RESPONSES IN IL-1Β–INFLAMED ARTICULAR CHONDROCYTES: A PROTEOMIC ANALYSIS},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  volume = {34},
  pages = {S83},
  doi = {10.1016/j.joca.2026.01.089}
}
Kostenlos starten →